Deelnemers

Heb je een vraag? Neem gerust contact met ons op.

Contact met Lifelines

Researchers

Do you have a question regarding working with Lifelines? Please contact us, we're happy to help you.

Contact us

Pers

We voorzien media graag van informatie en we behandelen graag verzoeken voor interviews, opnames en beeldmateriaal.

Stuur een e-mail

Contact

Participant selection in lung cancer screening: a validation of current risk-prediction criteria and why cancers are missed

Abstract: 
Background: Low-dose computed tomography (LDCT) screening in high-risk populations reduces lung cancer mortality. Current criteria for defining high-risk populations are mainly based on age and smoking status. This study aimed to evaluate the performance of age/smoking criteria and existing risk-prediction models identifying lung cancer cases within a Western general population.
Methods: Baseline data from the Dutch population-based Lifelines cohort, collected between 2006-2013 were linked to the Dutch cancer registry to confirm lung cancer diagnoses. Five-year lung cancer risk was estimated based on age/smoking selection criteria and published risk-prediction models. The number of individuals eligible for screening and lung cancer cases were determined, given the selection strategies applied. 
Results: Of 139,120 adult Lifelines participants, 218 (0.16%) developed lung cancer within 5 years of follow-up. Age/smoking criteria identified 4.9% to 7.4% participants as eligible for screening, but missed more than 53% of lung cancer cases. Risk-prediction models reduced the number of individuals eligible for screening by 30.8% to 57.3% relative to age/smoking criteria, at the cost of missing over 61% lung cancers. Of the missed cases, 44%-61% occurred in former smokers, 25%-40% in current smokers, and 41%-67% in individuals younger than 50. Among former smokers, 43%-70.1% had quit smoking >15 years prior to diagnosis. 
Conclusion: Current criteria for defining high-risk populations eligible for lung cancer screening miss 50-60% of individuals who develop lung cancer within 5-years. The challenge remains in identifying lung cancers that arise in individuals not considered as high risk by current eligibility criteria.
Keywords: Mass screening, lung neoplasms, risk assessment, prediction model, targeted screening.

Year of publication

2026

Journal

Cancers

Author(s)

Zhong, D.
Sidorenkov, G.
Greuter, M.J.W.
Jacobs, C.
de Jong, P.A.
Gietema, H.A.
et al.

Full publication

Click here to view the full publicationClick here to view the full publication

Tags